GP Strategies Corporation (GPX) Expected to Post Quarterly Sales of $125.01 Million
Wall Street analysts expect GP Strategies Corporation (NYSE:GPX) to announce sales of $125.01 million for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for GP Strategies Corporation’s earnings, with the lowest sales estimate coming in at $123.40 million and the highest estimate coming in at $127.62 million. GP Strategies Corporation reported sales of $121.98 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 2.5%. The company is expected to report its next quarterly earnings results before the market opens on Thursday, November 2nd.
On average, analysts expect that GP Strategies Corporation will report full-year sales of $125.01 million for the current financial year, with estimates ranging from $512.61 million to $515.73 million. For the next fiscal year, analysts anticipate that the company will report sales of $547.36 million per share, with estimates ranging from $538.24 million to $552.00 million. Zacks’ sales calculations are a mean average based on a survey of research firms that follow GP Strategies Corporation.
GP Strategies Corporation (NYSE:GPX) last announced its quarterly earnings results on Thursday, July 27th. The company reported $0.35 earnings per share for the quarter, beating analysts’ consensus estimates of $0.32 by $0.03. GP Strategies Corporation had a net margin of 4.27% and a return on equity of 12.56%. The business had revenue of $131.16 million during the quarter, compared to analysts’ expectations of $131.20 million. During the same period last year, the business earned $0.29 earnings per share. The business’s revenue for the quarter was up 4.5% on a year-over-year basis.
Several research analysts have recently weighed in on the stock. Barrington Research increased their price objective on shares of GP Strategies Corporation from $30.00 to $32.00 and gave the stock an “outperform” rating in a report on Friday, July 28th. TheStreet upgraded shares of GP Strategies Corporation from a “c+” rating to a “b-” rating in a report on Monday, July 31st. Zacks Investment Research upgraded shares of GP Strategies Corporation from a “hold” rating to a “buy” rating and set a $31.00 price objective on the stock in a report on Monday, July 31st. B. Riley reiterated a “neutral” rating and set a $27.00 price objective on shares of GP Strategies Corporation in a report on Friday, July 28th. Finally, ValuEngine upgraded shares of GP Strategies Corporation from a “hold” rating to a “buy” rating in a report on Friday, July 28th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. GP Strategies Corporation currently has a consensus rating of “Hold” and an average target price of $30.00.
Shares of GP Strategies Corporation (NYSE GPX) opened at 30.35 on Friday. The firm’s 50 day moving average is $29.81 and its 200-day moving average is $27.42. The firm has a market capitalization of $507.60 million, a PE ratio of 23.71 and a beta of 0.93. GP Strategies Corporation has a 12 month low of $22.70 and a 12 month high of $31.25.
In related news, Director Marshall S. Geller sold 7,691 shares of the stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $28.59, for a total transaction of $219,885.69. Following the completion of the sale, the director now owns 141,051 shares of the company’s stock, valued at approximately $4,032,648.09. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Marshall S. Geller sold 3,894 shares of the stock in a transaction that occurred on Wednesday, August 30th. The stock was sold at an average price of $28.64, for a total transaction of $111,524.16. Following the sale, the director now directly owns 141,051 shares of the company’s stock, valued at approximately $4,039,700.64. The disclosure for this sale can be found here. In the last three months, insiders have sold 21,317 shares of company stock valued at $608,101. Corporate insiders own 25.70% of the company’s stock.
Institutional investors and hedge funds have recently bought and sold shares of the stock. First Interstate Bank increased its position in GP Strategies Corporation by 102.2% during the 2nd quarter. First Interstate Bank now owns 7,785 shares of the company’s stock worth $206,000 after purchasing an additional 3,935 shares in the last quarter. American International Group Inc. increased its position in GP Strategies Corporation by 7.0% during the 1st quarter. American International Group Inc. now owns 7,838 shares of the company’s stock worth $198,000 after purchasing an additional 516 shares in the last quarter. Alliancebernstein L.P. acquired a new stake in GP Strategies Corporation during the 2nd quarter worth approximately $214,000. Susquehanna International Group LLP acquired a new stake in GP Strategies Corporation during the 2nd quarter worth approximately $222,000. Finally, Bessemer Group Inc. increased its position in GP Strategies Corporation by 24.7% during the 2nd quarter. Bessemer Group Inc. now owns 8,950 shares of the company’s stock worth $236,000 after purchasing an additional 1,770 shares in the last quarter. 88.40% of the stock is owned by hedge funds and other institutional investors.
GP Strategies Corporation Company Profile
GP Strategies Corporation (GP Strategies) is a global performance improvement solutions provider of sales and technical training, e-learning solutions, management consulting and engineering services. The Company operates in five segments: Learning Solutions, Professional & Technical Services, Sandy Training & Marketing, RWD and Energy Services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for GP Strategies Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GP Strategies Corporation and related companies with MarketBeat.com's FREE daily email newsletter.